Intervacc is trading at €0.07, up +5.02%, with no clear company-specific catalyst identified for September 16, 2026.
- Intervacc announced participation in the Swiss Nordic Bio Conference on September 15; the release described a future October 1 presentation and did not link it to the share-price move.
- Broader biotechnology sentiment was weak, so sector conditions do not clearly explain the gain.
- The move remains an unexplained, potentially low-liquidity fluctuation.